News
06/30/2014
The University of Arizona Sarver Heart Center celebrated the graduation of five fellows from the Cardiovascular Medicine Fellowship Program and two from the Interventional Cardiology Fellowship Program this June.
06/19/2014
Heart disease is the No. 1 killer of men, and the hearts of one of eight men over age 40 will at some point suddenly stop beating – an event known as sudden cardiac arrest. June is both National Men's Health Month and CPR and AED Awareness Month, making it a good time to revisit ways to prevent heart disease.
06/16/2014
PolyNova, a startup company that has grown out of an inter-institutional collaboration between the University of Arizona (UA) and Stony Brook University, announced it is developing a novel polymeric prosthetic heart valve.
06/15/2014
"Women of the Heart" and "Sweitzer Brings Researchers Together" featuring Nancy K. Sweitzer, MD, PhD, Carol Gregorio, PhD, and Jil C. Tardiff, MD, PhD, talking about leadership, cardiology, research, and the next generation.
06/11/2014
PolyNova, a startup company that has grown out of an inter-institutional collaboration between the University of Arizona and Stony Brook University, is developing a novel polymeric prosthetic heart valve. Dr. Marvin J. Slepian, UA professor of medicine and biomedical engineering and a cardiologist at the UA Sarver Heart Center, is the founding CEO of PolyNova.
06/09/2014
Tucson's health community is getting an upgrade. Some feel the revival of the heart transplant program will make UAMC an international leader once again in heart transplants and research.
06/03/2014
June is National Men’s Health Month and National CPR & AED Awareness Month
05/28/2014
The University of Arizona Medical Center – University Campus has reactivated its Heart Transplant Program after receiving approval from the United Network of Organ Sharing (UNOS).
04/17/2014
Dr. Slepian and Danny Bluestein, PhD, professor of bioengineering at Stony Brook University in New York, co-authored a review article in the New England Journal of Medicine (April 17, 2014), citing the benefits of hydrophobic light-activated adhesive (HLAA), a fluid, blood-resistant tissue glue that can be applied as a liquid before a procedure is performed and activated on demand to adhere, cure and bond.
04/16/2014
The UV light-activated adhesive created a water-tight seal in seconds that stayed intact in the face of high pressure and flowing blood but biodegrades over time, explained Danny Bluestein, PhD, of New York's Stony Brook University, and Marvin J. Slepian, MD, of the Sarver Heart Center in Tucson, Ariz.